CareDx Inc (CDNA):企業の製品パイプライン分析2018

【英語タイトル】CareDx Inc (CDNA) - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C2878)・商品コード:DATA904C2878
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CareDx Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CareDx Inc Company Overview 4
CareDx Inc Company Snapshot 4
CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CareDx Inc – Pipeline Analysis Overview 6
CareDx Inc – Key Facts 6
CareDx Inc – Major Products and Services 7
CareDx Inc Pipeline Products by Development Stage 8
CareDx Inc Pipeline Products Overview 10
cfDNA Assay – Heart 10
cfDNA Assay – Heart Product Overview 10
cfDNA Assay – Liver 11
cfDNA Assay – Liver Product Overview 11
cfDNA Assay – Lung 12
cfDNA Assay – Lung Product Overview 12
Diagnostic Test – Crohn’s Disease 13
Diagnostic Test – Crohn’s Disease Product Overview 13
Diagnostic Test – Multiple Sclerosis 14
Diagnostic Test – Multiple Sclerosis Product Overview 14
Diagnostic Test – Rheumatoid Arthritis 15
Diagnostic Test – Rheumatoid Arthritis Product Overview 15
Diagnostic Test – Sjogren’s Syndrome 16
Diagnostic Test – Sjogren’s Syndrome Product Overview 16
Diagnostic Test – Systemic Lupus Erythematosus 17
Diagnostic Test – Systemic Lupus Erythematosus Product Overview 17
Olerup QTYPE 18
Olerup QTYPE Product Overview 18
Post Transplant Management-Lung Transplant 19
Post Transplant Management-Lung Transplant Product Overview 19
CareDx Inc – Key Competitors 20
CareDx Inc – Key Employees 21
CareDx Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
CareDx Inc, Recent Developments 23
Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 23
Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 23
Jun 01, 2018: Key CareDx Events Scheduled at American Transplant Congress 2018 23
May 10, 2018: CareDx Reports First Quarter Results 24
May 01, 2018: CareDx Activities at American Transplant Congress 25
Apr 13, 2018: Olerup QTYPE Receives CE Mark Certification 26
Apr 10, 2018: CareDx Launches HeartCare for Heart Transplant Recipients 26
Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 27
Mar 18, 2018: Olerup QTYPE now available on Applied Biosystems platforms 28
Feb 05, 2018: CareDx Leadership in cfDNA Highlighted at CEoT 28
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CareDx Inc Pipeline Products by Equipment Type 5
CareDx Inc Pipeline Products by Indication 5
CareDx Inc, Key Facts 6
CareDx Inc, Major Products and Services 7
CareDx Inc Number of Pipeline Products by Development Stage 8
CareDx Inc Pipeline Products Summary by Development Stage 9
cfDNA Assay - Heart - Product Status 10
cfDNA Assay - Heart - Product Description 10
cfDNA Assay - Liver - Product Status 11
cfDNA Assay - Liver - Product Description 11
cfDNA Assay - Lung - Product Status 12
cfDNA Assay - Lung - Product Description 12
Diagnostic Test - Crohn's Disease - Product Status 13
Diagnostic Test - Crohn's Disease - Product Description 13
Diagnostic Test - Multiple Sclerosis - Product Status 14
Diagnostic Test - Multiple Sclerosis - Product Description 14
Diagnostic Test - Rheumatoid Arthritis - Product Status 15
Diagnostic Test - Rheumatoid Arthritis - Product Description 15
Diagnostic Test - Sjogren's Syndrome - Product Status 16
Diagnostic Test - Sjogren's Syndrome - Product Description 16
Diagnostic Test - Systemic Lupus Erythematosus - Product Status 17
Diagnostic Test - Systemic Lupus Erythematosus - Product Description 17
Olerup QTYPE - Product Status 18
Olerup QTYPE - Product Description 18
Post Transplant Management-Lung Transplant - Product Status 19
Post Transplant Management-Lung Transplant - Product Description 19
CareDx Inc, Key Employees 21
CareDx Inc, Subsidiaries 22
Glossary 32

List of Figures
CareDx Inc Pipeline Products by Equipment Type 5
CareDx Inc Pipeline Products by Development Stage 8

★調査レポート[CareDx Inc (CDNA):企業の製品パイプライン分析2018] (コード:DATA904C2878)販売に関する免責事項を必ずご確認ください。
★調査レポート[CareDx Inc (CDNA):企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆